Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 2, 2013, Pages 137-143

  Navarro Millán, Iris ^a   Chen, Lang ^a   Greenberg, Jeffrey D ^b   Pappas, Dimitrios A ^c   Curtis, Jeffrey R ^a  

^a University of Alabama at Birmingham   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia University ^*  (United States)

Author keywords

CRP; Remission; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; CERTOLIZUMAB PEGOL; ETANERCEPT; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; VISUAL ANALOG SCALE;

CRP; REMISSION; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84886100878     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.02.002     Document Type: Article

References (20)

1. Smolen J.S., Breedveld F.C., Schiff M.H., Kalden J.R., Emery P., Eberl G., et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003, 42(2):244-257.
2. Smolen J.S., Aletaha D. Activity assessments in rheumatoid arthritis. Curr Opin Rheumatol 2008, 20(3):306-313.
3. Makinen H., Kautiainen H., Hannonen P., Sokka T. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?. Ann Rheum Dis 2005, 64(10):1410-1413.
4. Mierau M., Schoels M., Gonda G., Fuchs J., Aletaha D., Smolen J.S. Assessing remission in clinical practice. Rheumatology (Oxford) 2007, 46(6):975-979.
5. Felson D.T., Smolen J.S., Wells G., Zhang B., van Tuyl L.H., Funovits J., et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011, 70(3):404-413.
6. Radner H., Smolen J.S., Aletaha D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann Rheum Dis 2010, 69(3):536-541.
7. Krishnan E., Hakkinen A., Sokka T., Hannonen P. Impact of age and comorbidities on the criteria for remission and response in rheumatoid arthritis. Ann Rheum Dis 2005, 64(9):1350-1352.
8. Iking-Konert C., Aringer M., Wollenhaupt J., Mosch T., Tuerk S., Feist E., et al. Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria. Ann Rheum Dis 2011.
9. Lee Y.C., Cui J., Lu B., Frits M.L., Iannaccone C.K., Shadick N.A., et al. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther 2011, 13(3):R83.
10. Gulfe A., Aletaha D., Saxne T., Geborek P. Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents. BMC Musculoskelet Disord 2009, 10:41.
11. Shahouri S.H., Michaud K., Mikuls T.R., Caplan L., Shaver T.S., Anderson J.D., et al. Remission of rheumatoid arthritis in clinical practice: Application of the ACR/EULAR 2011 remission criteria. Arthritis Rheum. 2011.
12. Prince F.H., Bykerk V.P., Shadick N.A., Lu B., Cui J., Frits M., et al. Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis Res Ther 2012, 14(2):R68.
13. Kremer J. The CORRONA database. Ann Rheum Dis 2005, 64(Suppl. 4):iv37-iv41.
14. Kremer J.M. The CORRONA database. Autoimmun Rev 2006, 5(1):46-54. [Review].
15. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(3):315-324. [Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
16. Pope J.E., Khanna D., Norrie D., Ouimet J.M. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rheumatol 2009, 36(2):254-259. [Comparative Study Research Support, Non-U.S. Gov't].
17. Furst D.E., Pangan A.L., Harrold L.R., Chang H., Reed G., Kremer J.M., et al. Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry. Arthritis Care Res (Hoboken) 2011, 63(6):856-864. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't].
18. Jawaheer D, Messing S, Reed G, Ranganath VK, Kremer JM, Louie JS, et al. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2012;64(12):1811-8.
19. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59(7):574-580.
20. Hu F.B., Meigs J.B., Li T.Y., Rifai N., Manson J.E. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004, 53(3):693-700.